世界の患者シミュレーター市場2023年-2032年:製品種類別(成人患者シミュレーター、幼児シミュレーター、出産シミュレーター)、技術別(高忠実度シミュレーター、中忠実度シミュレーター、低忠実度シミュレーター)、エンドユーザー別(病院、学術機関)

【英語タイトル】Patient Simulator Market By Product Type (Adult Patient Simulator, Infant Simulator, Childbirth Simulator), By Technology (High-fidelity Simulators, Medium-fidelity Simulators, Low-fidelity Simulators), By End User (Hospital, Academic Institutions): Global Opportunity Analysis and Industry Forecast, 2023-2032

Allied Market Researchが出版した調査資料(ALD23SEP120)・商品コード:ALD23SEP120
・発行会社(調査会社):Allied Market Research
・発行日:2023年4月
・ページ数:250
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:生命科学
◆販売価格オプション(消費税別)
Online Only(1名閲覧、印刷不可)USD3,570 ⇒換算¥542,640見積依頼/購入/質問フォーム
Single User(1名閲覧)USD5,730 ⇒換算¥870,960見積依頼/購入/質問フォーム
Enterprise User(閲覧人数無制限)USD9,600 ⇒換算¥1,459,200見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

患者シミュレーター市場は、2022年に5億3,026万ドルと評価され、2023年から2032年までの年平均成長率は8.7%で、2032年には12億2,183万ドルに達すると予測されています。患者シミュレーションは、管理された環境で実際の臨床シナリオを再現するために医療教育やトレーニングで使用される教育・学習手法です。シミュレーションマネキン、バーチャルリアリティツール、標準化された患者を使用し、学習者に患者ケアの実体験を提供します。患者シミュレーションにより、医療従事者は患者の安全を脅かすことなく、臨床スキルや意思決定能力を練習し、向上させることができます。この手法には、臨床スキルの向上、自信の向上、チームワークの強化、医療ミスの減少など、いくつかの利点があります。
患者シミュレーターの世界市場成長の主な要因は、医療従事者に対する需要の急増です。世界的な医療従事者不足により、安全で管理された環境で学習者に実地経験を提供するシミュレーションベースのトレーニングに対する需要が高まっています。このため、学習者が臨床シナリオを没入的かつリアルに体験できる高度な患者シミュレーション技術の開発が進んでいます。

さらに、政府組織によるイニシアチブの高まりと患者の安全性向上のニーズが市場成長の原動力となっています。医療ミスは患者を傷つける主な原因であり、多額の医療費につながります。シミュレーションベースのトレーニングは、医療従事者の臨床スキルと意思決定能力を向上させ、医療ミスのリスクを減らし、患者の安全性を向上させます。その結果、医療機関はスタッフのトレーニングや有害事象のリスク低減のために患者シミュレーション技術への投資を増やしています。そのため、市場成長の原動力となる可能性があります。

しかし、患者シミュレーション技術のコストが高く、訓練を受けたインストラクターや施設が限られていることが、その普及を妨げる大きな要因となっています。また、継続的なメンテナンスやアップデートの必要性、シミュレーションに基づく評価の妥当性や信頼性に対する懸念も、市場成長の妨げとなる要因です。

さらに、診断と治療に熟練した専門家を必要とする慢性疾患の負担が増加していることも、市場の成長を促進すると予想されます。また、低侵襲手術の急増と技術の進歩は、予測期間中に世界の患者シミュレーター市場の成長に有利な機会を提供することが期待されています。

患者シミュレーター市場は、製品タイプ、技術、エンドユーザー、地域に基づいてセグメント化されます。製品タイプ別では、市場は成人患者シミュレーター、乳児シミュレーター、出産シミュレーターに分類されます。技術ベースでは、高忠実度シミュレーター、中忠実度シミュレーター、低忠実度シミュレーターに分別されます。エンドユーザー別では、病院と学術機関に細分化されます。地域別では、北米(米国、カナダ、メキシコ)、欧州(ドイツ、フランス、英国、イタリア、スペイン、その他欧州)、アジア太平洋(日本、中国、オーストラリア、インド、韓国、その他アジア太平洋)、LAMEA(ブラジル、南アフリカ、サウジアラビア、その他LAMEA)にわたって市場を分析しています。
患者シミュレーター市場で事業を展開している主なプレイヤーは、CAE Inc.、Gaumard Scientific、Mentice AB、Surgical Science Sweden AB、京都科学株式会社、Laerdal Medical、MedVision、MEDICAL-X.、Simulab Corporation、Limbs & Things LTDです。

ステークホルダーにとっての主な利点
本レポートは、2022年から2032年までの患者シミュレーター市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、患者シミュレーターの市場機会を特定します。
主要な促進要因、阻害要因、機会に関する情報とともに市場調査を提供します。
ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益重視のビジネス決定を行い、サプライヤーとバイヤーのネットワークを強化できるようにします。
患者シミュレーター市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
各地域の主要国を世界市場への収益貢献度に応じてマッピングしています。
市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
地域別および世界の患者シミュレーター市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

主要市場セグメント
技術別
高忠実度シミュレーター
中忠実度シミュレーター
低忠実度シミュレーター

エンドユーザー別
病院
学術機関

製品タイプ別
成人患者シミュレーター
乳幼児シミュレーター
出産シミュレーター

地域別
北米
アメリカ
カナダ
メキシコ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
その他のヨーロッパ
アジア太平洋
日本
中国
オーストラリア
インド
韓国
その他のアジア太平洋地域
LAMEA
ブラジル
サウジアラビア
南アフリカ
その他の地域

主な市場プレイヤー
○ CAE Inc.
○ Gaumard Scientific
○ Kyoto Kagaku Co., Ltd.
○ Laerdal Medical
○ Limbs & Things LTD
○ MEDICAL-X
○ MedVision
○ Mentice AB
○ Simulab Corporation
○ Surgical Science Sweden AB

第1章:イントロダクション
第2章:エグゼクティブサマリー
第3章:市場概要
第4章:患者シミュレータ市場、製品タイプ別
第5章:患者シミュレータ市場、技術別
第6章:患者シミュレータ市場、エンドユーザー別
第7章:患者シミュレータ市場、地域別
第8章:競争状況
第9章:企業情報

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in focus on patient safety
3.4.1.2. Technological advancements and adoption infield of healthcare
3.4.1.3. Growth in adoption of minimally invasive surgeries

3.4.2. Restraints
3.4.2.1. High cost of patient simulators

3.4.3. Opportunities
3.4.3.1. Growth in opportunities in emerging markets

3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: PATIENT SIMULATOR MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Adult Patient Simulator
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Infant Simulator
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Childbirth Simulator
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: PATIENT SIMULATOR MARKET, BY TECHNOLOGY
5.1. Overview
5.1.1. Market size and forecast
5.2. High-fidelity Simulators
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Medium-fidelity Simulators
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Low-fidelity Simulators
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: PATIENT SIMULATOR MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospital
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Academic Institutions
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
CHAPTER 7: PATIENT SIMULATOR MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Product Type
7.2.3. Market size and forecast, by Technology
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Product Type
7.2.5.1.3. Market size and forecast, by Technology
7.2.5.1.4. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Product Type
7.2.5.2.3. Market size and forecast, by Technology
7.2.5.2.4. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Product Type
7.2.5.3.3. Market size and forecast, by Technology
7.2.5.3.4. Market size and forecast, by End User
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Product Type
7.3.3. Market size and forecast, by Technology
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Product Type
7.3.5.1.3. Market size and forecast, by Technology
7.3.5.1.4. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Product Type
7.3.5.2.3. Market size and forecast, by Technology
7.3.5.2.4. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Product Type
7.3.5.3.3. Market size and forecast, by Technology
7.3.5.3.4. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Product Type
7.3.5.4.3. Market size and forecast, by Technology
7.3.5.4.4. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Product Type
7.3.5.5.3. Market size and forecast, by Technology
7.3.5.5.4. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Product Type
7.3.5.6.3. Market size and forecast, by Technology
7.3.5.6.4. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Product Type
7.4.3. Market size and forecast, by Technology
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Product Type
7.4.5.1.3. Market size and forecast, by Technology
7.4.5.1.4. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Product Type
7.4.5.2.3. Market size and forecast, by Technology
7.4.5.2.4. Market size and forecast, by End User
7.4.5.3. Australia
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Product Type
7.4.5.3.3. Market size and forecast, by Technology
7.4.5.3.4. Market size and forecast, by End User
7.4.5.4. India
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Product Type
7.4.5.4.3. Market size and forecast, by Technology
7.4.5.4.4. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Product Type
7.4.5.5.3. Market size and forecast, by Technology
7.4.5.5.4. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Product Type
7.4.5.6.3. Market size and forecast, by Technology
7.4.5.6.4. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Product Type
7.5.3. Market size and forecast, by Technology
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Product Type
7.5.5.1.3. Market size and forecast, by Technology
7.5.5.1.4. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Product Type
7.5.5.2.3. Market size and forecast, by Technology
7.5.5.2.4. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Product Type
7.5.5.3.3. Market size and forecast, by Technology
7.5.5.3.4. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Product Type
7.5.5.4.3. Market size and forecast, by Technology
7.5.5.4.4. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Laerdal Medical
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.2. CAE Inc.
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. Gaumard Scientific
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.4. Kyoto Kagaku Co., Ltd.
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.5. MEDICAL-X
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.6. MedVision
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.7. Simulab Corporation
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.8. Limbs & Things LTD
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.9. Surgical Science Sweden AB
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.9.7. Key strategic moves and developments
9.10. Mentice AB
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
9.10.7. Key strategic moves and developments

LIST OF TABLES
TABLE 01. GLOBAL PATIENT SIMULATOR MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 02. PATIENT SIMULATOR MARKET FOR ADULT PATIENT SIMULATOR, BY REGION, 2022-2032 ($MILLION)
TABLE 03. PATIENT SIMULATOR MARKET FOR INFANT SIMULATOR, BY REGION, 2022-2032 ($MILLION)
TABLE 04. PATIENT SIMULATOR MARKET FOR CHILDBIRTH SIMULATOR, BY REGION, 2022-2032 ($MILLION)
TABLE 05. GLOBAL PATIENT SIMULATOR MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 06. PATIENT SIMULATOR MARKET FOR HIGH-FIDELITY SIMULATORS, BY REGION, 2022-2032 ($MILLION)
TABLE 07. PATIENT SIMULATOR MARKET FOR MEDIUM-FIDELITY SIMULATORS, BY REGION, 2022-2032 ($MILLION)
TABLE 08. PATIENT SIMULATOR MARKET FOR LOW-FIDELITY SIMULATORS, BY REGION, 2022-2032 ($MILLION)
TABLE 09. GLOBAL PATIENT SIMULATOR MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 10. PATIENT SIMULATOR MARKET FOR HOSPITAL, BY REGION, 2022-2032 ($MILLION)
TABLE 11. PATIENT SIMULATOR MARKET FOR ACADEMIC INSTITUTIONS, BY REGION, 2022-2032 ($MILLION)
TABLE 12. PATIENT SIMULATOR MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 13. NORTH AMERICA PATIENT SIMULATOR MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 14. NORTH AMERICA PATIENT SIMULATOR MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 15. NORTH AMERICA PATIENT SIMULATOR MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 16. NORTH AMERICA PATIENT SIMULATOR MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 17. U.S. PATIENT SIMULATOR MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 18. U.S. PATIENT SIMULATOR MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 19. U.S. PATIENT SIMULATOR MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 20. CANADA PATIENT SIMULATOR MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 21. CANADA PATIENT SIMULATOR MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 22. CANADA PATIENT SIMULATOR MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 23. MEXICO PATIENT SIMULATOR MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 24. MEXICO PATIENT SIMULATOR MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 25. MEXICO PATIENT SIMULATOR MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 26. EUROPE PATIENT SIMULATOR MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 27. EUROPE PATIENT SIMULATOR MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 28. EUROPE PATIENT SIMULATOR MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 29. EUROPE PATIENT SIMULATOR MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 30. GERMANY PATIENT SIMULATOR MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 31. GERMANY PATIENT SIMULATOR MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 32. GERMANY PATIENT SIMULATOR MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 33. FRANCE PATIENT SIMULATOR MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 34. FRANCE PATIENT SIMULATOR MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 35. FRANCE PATIENT SIMULATOR MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 36. UK PATIENT SIMULATOR MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 37. UK PATIENT SIMULATOR MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 38. UK PATIENT SIMULATOR MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 39. ITALY PATIENT SIMULATOR MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 40. ITALY PATIENT SIMULATOR MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 41. ITALY PATIENT SIMULATOR MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 42. SPAIN PATIENT SIMULATOR MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 43. SPAIN PATIENT SIMULATOR MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 44. SPAIN PATIENT SIMULATOR MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 45. REST OF EUROPE PATIENT SIMULATOR MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 46. REST OF EUROPE PATIENT SIMULATOR MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 47. REST OF EUROPE PATIENT SIMULATOR MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 48. ASIA-PACIFIC PATIENT SIMULATOR MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 49. ASIA-PACIFIC PATIENT SIMULATOR MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 50. ASIA-PACIFIC PATIENT SIMULATOR MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 51. ASIA-PACIFIC PATIENT SIMULATOR MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 52. JAPAN PATIENT SIMULATOR MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 53. JAPAN PATIENT SIMULATOR MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 54. JAPAN PATIENT SIMULATOR MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 55. CHINA PATIENT SIMULATOR MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 56. CHINA PATIENT SIMULATOR MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 57. CHINA PATIENT SIMULATOR MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 58. AUSTRALIA PATIENT SIMULATOR MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 59. AUSTRALIA PATIENT SIMULATOR MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 60. AUSTRALIA PATIENT SIMULATOR MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 61. INDIA PATIENT SIMULATOR MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 62. INDIA PATIENT SIMULATOR MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 63. INDIA PATIENT SIMULATOR MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 64. SOUTH KOREA PATIENT SIMULATOR MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 65. SOUTH KOREA PATIENT SIMULATOR MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 66. SOUTH KOREA PATIENT SIMULATOR MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 67. REST OF ASIA-PACIFIC PATIENT SIMULATOR MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 68. REST OF ASIA-PACIFIC PATIENT SIMULATOR MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC PATIENT SIMULATOR MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 70. LAMEA PATIENT SIMULATOR MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 71. LAMEA PATIENT SIMULATOR MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 72. LAMEA PATIENT SIMULATOR MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 73. LAMEA PATIENT SIMULATOR MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 74. BRAZIL PATIENT SIMULATOR MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 75. BRAZIL PATIENT SIMULATOR MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 76. BRAZIL PATIENT SIMULATOR MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 77. SAUDI ARABIA PATIENT SIMULATOR MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 78. SAUDI ARABIA PATIENT SIMULATOR MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 79. SAUDI ARABIA PATIENT SIMULATOR MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 80. SOUTH AFRICA PATIENT SIMULATOR MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 81. SOUTH AFRICA PATIENT SIMULATOR MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 82. SOUTH AFRICA PATIENT SIMULATOR MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 83. REST OF LAMEA PATIENT SIMULATOR MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 84. REST OF LAMEA PATIENT SIMULATOR MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 85. REST OF LAMEA PATIENT SIMULATOR MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 86. LAERDAL MEDICAL: KEY EXECUTIVES
TABLE 87. LAERDAL MEDICAL: COMPANY SNAPSHOT
TABLE 88. LAERDAL MEDICAL: PRODUCT SEGMENTS
TABLE 89. LAERDAL MEDICAL: PRODUCT PORTFOLIO
TABLE 90. CAE INC.: KEY EXECUTIVES
TABLE 91. CAE INC.: COMPANY SNAPSHOT
TABLE 92. CAE INC.: PRODUCT SEGMENTS
TABLE 93. CAE INC.: PRODUCT PORTFOLIO
TABLE 94. CAE INC.: KEY STRATERGIES
TABLE 95. GAUMARD SCIENTIFIC: KEY EXECUTIVES
TABLE 96. GAUMARD SCIENTIFIC: COMPANY SNAPSHOT
TABLE 97. GAUMARD SCIENTIFIC: PRODUCT SEGMENTS
TABLE 98. GAUMARD SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 99. KYOTO KAGAKU CO., LTD.: KEY EXECUTIVES
TABLE 100. KYOTO KAGAKU CO., LTD.: COMPANY SNAPSHOT
TABLE 101. KYOTO KAGAKU CO., LTD.: PRODUCT SEGMENTS
TABLE 102. KYOTO KAGAKU CO., LTD.: PRODUCT PORTFOLIO
TABLE 103. MEDICAL-X: KEY EXECUTIVES
TABLE 104. MEDICAL-X: COMPANY SNAPSHOT
TABLE 105. MEDICAL-X: PRODUCT SEGMENTS
TABLE 106. MEDICAL-X: PRODUCT PORTFOLIO
TABLE 107. MEDVISION: KEY EXECUTIVES
TABLE 108. MEDVISION: COMPANY SNAPSHOT
TABLE 109. MEDVISION: PRODUCT SEGMENTS
TABLE 110. MEDVISION: PRODUCT PORTFOLIO
TABLE 111. SIMULAB CORPORATION: KEY EXECUTIVES
TABLE 112. SIMULAB CORPORATION: COMPANY SNAPSHOT
TABLE 113. SIMULAB CORPORATION: PRODUCT SEGMENTS
TABLE 114. SIMULAB CORPORATION: PRODUCT PORTFOLIO
TABLE 115. LIMBS & THINGS LTD: KEY EXECUTIVES
TABLE 116. LIMBS & THINGS LTD: COMPANY SNAPSHOT
TABLE 117. LIMBS & THINGS LTD: PRODUCT SEGMENTS
TABLE 118. LIMBS & THINGS LTD: PRODUCT PORTFOLIO
TABLE 119. SURGICAL SCIENCE SWEDEN AB: KEY EXECUTIVES
TABLE 120. SURGICAL SCIENCE SWEDEN AB: COMPANY SNAPSHOT
TABLE 121. SURGICAL SCIENCE SWEDEN AB: PRODUCT SEGMENTS
TABLE 122. SURGICAL SCIENCE SWEDEN AB: PRODUCT PORTFOLIO
TABLE 123. SURGICAL SCIENCE SWEDEN AB: KEY STRATERGIES
TABLE 124. MENTICE AB: KEY EXECUTIVES
TABLE 125. MENTICE AB: COMPANY SNAPSHOT
TABLE 126. MENTICE AB: PRODUCT SEGMENTS
TABLE 127. MENTICE AB: PRODUCT PORTFOLIO
TABLE 128. MENTICE AB: KEY STRATERGIES

★調査レポート[世界の患者シミュレーター市場2023年-2032年:製品種類別(成人患者シミュレーター、幼児シミュレーター、出産シミュレーター)、技術別(高忠実度シミュレーター、中忠実度シミュレーター、低忠実度シミュレーター)、エンドユーザー別(病院、学術機関)] (コード:ALD23SEP120)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の患者シミュレーター市場2023年-2032年:製品種類別(成人患者シミュレーター、幼児シミュレーター、出産シミュレーター)、技術別(高忠実度シミュレーター、中忠実度シミュレーター、低忠実度シミュレーター)、エンドユーザー別(病院、学術機関)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆